Based on the power of attorney granted at the annual general meetings of
NattoPharma ASA ("NattoPharma" or "Company") on May 20th, 2016, the Board of
Directors of NattoPharma has in board proceedings July 21st, 2016 granted a
total of 312 500 options to management, key employees and strategic partners.
The following persons have been granted options;
Name Position / Granted Options prior Options after grant
Function Options to grant
Daniel H CEO 75.000 0 75.000
Rosenbaum
Kjetil CFO 37.500 0 37.500
Ramsøy
Eric SVP Global Sales & 25.000 0 25.000
Anderson Marketing
Rudi de VP Sales & 25.000 0 25.000
Man Marketing Europe &
Asia
William VP Global 25.000 0 25.000
Sommer Development and
Regulatory
Laura Finance Manager 12.500 0 12.500
Bakker
Mike Strategic Partner 12.500 0 12.500
Dornish
Hogne Vik CMO 100.000 0 100.000
The options have an exercise price equal the volume weighted average price the
10 last trading days as of July 21st 2016, which is equal to NOK 9,16.
The options granted are vested immediately, and may be exercised up to and
including March 31st 2018.
* * *
For more information, please contact:
Kjetil Ramsøy, Chief Financial Officer
E-mail: kjetil.ramsoy@nattopharma.com
This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
NATTO: OPTIONS GRANTED
| Source: NATTO PHARMA
Attachments
